Zenapax Smart humanized Anti-Tac antibody targeted at the interleukin-2 receptor on activated T cells: Partner Hoffmann-La Roche began a Phase III trial in 250

Protein Design Labs Inc. (PDLI), Mountain View, Calif. Product: Zenapax Smart humanized Anti-Tac antibody targeted at the interleukin-2 receptor on activated T cells Indication: Prevent acute kidney ...